Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Baolan LI"'
Autor:
Shun Lu, Xiaorong Dong, Hong Jian, Jianhua Chen, Gongyan Chen, Yuping Sun, Yinghua Ji, Ziping Wang, Jianhua Shi, Junguo Lu, Shaoshui Chen, Dongqing Lv, Guojun Zhang, Chunling Liu, Juan Li, Xinmin Yu, Zhong Lin, Zhuang Yu, Zhehai Wang, Jiuwei Cui, Xingxiang Xu, Jian Fang, Jifeng Feng, Zhi Xu, Rui Ma, Jie Hu, Nong Yang, Xiangdong Zhou, Xiaohong Wu, Chengping Hu, Zhihong Zhang, You Lu, Yanping Hu, Liyan Jiang, Qiming wang, Renhua Guo, Jianying Zhou, Baolan Li, Chunhong Hu, Wancheng Tong, Helong Zhang, Lin Ma, Yuan Chen, Zhijun Jie, Yu Yao, Longzhen Zhang, Jie Weng, Weidong Li, Jianping Xiong, Xianwei Ye, Jianchun Duan, Haihua Yang, Meili Sun, Hongying Wei, Jiawei Wei, Zheyu Zhang, Qiong Wu
Publikováno v:
Cancer Communications, Vol 44, Iss 9, Pp 1005-1017 (2024)
Abstract Background The initial randomized, double‐blinded, actively controlled, phase III ANEAS study (NCT03849768) demonstrated that aumolertinib showed superior efficacy relative to gefitinib as first‐line therapy in epidermal growth factor re
Externí odkaz:
https://doaj.org/article/2b6ae05d34ee40d883ed46122a1d5428
Autor:
Xiaomi Li, Li Tong, Shan Wang, Jiaqi Yu, Baohua Lu, Qunhui Wang, Mingming Hu, Jinxiang Wu, Jing Yu, Baolan Li, Tongmei Zhang
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Immune checkpoint inhibitors (ICIs) had modest advances in the treatment of extensive-stage small cell lung cancer (ES-SCLC) in clinical trials, but there is a lack of biomarkers for prognosis in clinical practice. Methods We retr
Externí odkaz:
https://doaj.org/article/f926df4306a64c43b96273e537cb4ea9
Autor:
Yuanrui Li, Baolan Li, Weixin Zheng, Jin Zhou, Jing Wen, Jinmei Dong, Chenggong Chang, Qiang Wang
Publikováno v:
Carbon Capture Science & Technology, Vol 13, Iss , Pp 100301- (2024)
With the extensive utilization of lithium-ion battery in the electric vehicle and energy storage field, the consumption of lithium has been sharply increasing. Lithium resource occurrence area were facing increasing environmental pressure, particular
Externí odkaz:
https://doaj.org/article/7f12ac62b138419dbd47d8b6e7ebfa2f
Autor:
Cong Zhao, Li Tong, Bin Liu, Fei Qi, Zhiyun Zhang, Yi Guo, Yanxia Liu, Ying Wang, Lina Zhang, Baohua Lu, Baolan Li, Tongmei Zhang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Hepatocyte growth factor (HGF) is a peptide-containing multifunctional cytokine, which is overexpressed and/or activated in multiple malignancies and is reported to be associated with tumor development and inferior survival. At pr
Externí odkaz:
https://doaj.org/article/f270c847156348d9b5bf9ed95e9493e3
Autor:
Ying Wang, Yanxia Liu, Zhiyun Zhang, Baohua Lu, Yuan Gao, Li Tong, Mingming Hu, Peter Ping Lin, Baolan Li, Tongmei Zhang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Purpose This study aimed to investigate the clinical utility of diverse aneuploid circulating tumor cell (CTC) subtypes and particularly CTC-associated white blood cell (CTC-WBC) clusters in predicting treatment response, prognosis and real-
Externí odkaz:
https://doaj.org/article/b1e4cf2078b74e04bf4f05333974cccb
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Purpose For the first-line treatment of KRAS mutant non-small cell lung cancer (NSCLC) patients, immunotherapy or platinum-based chemotherapy are the main treatment method. Here, we investigated the clinical efficacy and prognosis those two
Externí odkaz:
https://doaj.org/article/578ef8698f604edca4da4c0990140976
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 17 (2023)
Background: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have limited or no response in some certain patients of non-small-cell lung cancer (NSCLC). However, real-world survival analyses comparing clinical data and EGFR-pla
Externí odkaz:
https://doaj.org/article/894937961e234022be548af3d9dc93b1
Autor:
Tongmei Zhang, Lina Zhang, Yuan Gao, Ying Wang, Yanxia Liu, Hongmei Zhang, Qunhui Wang, Fanbin Hu, Jie Li, Jinjing Tan, Daisy Dandan Wang, Olivier Gires, Peter Ping Lin, Baolan Li
Publikováno v:
Molecular Oncology, Vol 15, Iss 11, Pp 2891-2909 (2021)
Prognosticating the efficacy of anti‐angiogenic therapy through longitudinal monitoring and early detection of treatment resistance in cancer patients remain highly challenging. In this study, co‐detection and comprehensive phenotypic and karyoty
Externí odkaz:
https://doaj.org/article/25e5cf5fcef84a67b539d56385114b3d
Autor:
Jianhua Shi, Guimin Chen, Haitao Wang, Xiuxiu Wang, Baohui Han, Kai Li, Qiming Wang, Li Zhang, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Yi Luo, Lin Wu, Xiuwen Wang, Kejun Nan, Faguang Jin, Jian Dong, Baolan Li, Zhian Liu
Publikováno v:
Thoracic Cancer, Vol 12, Iss 17, Pp 2345-2351 (2021)
Abstract Background There is a lack of targeted therapeutic options for squamous cell lung cancer (SCC). Accelerated hypertension is an issue with many targeted therapies for lung cancer. This study aimed to analyze the efficacy of anlotinib, based o
Externí odkaz:
https://doaj.org/article/e503822267b54182b44be20d575273a6
Autor:
Ying WANG, Yi GUO, Haifeng LIN, Lina ZHANG, Hongmei ZHANG, Qunhui WANG, Fanbin HU, Jie LI, Baolan LI, Tongmei ZHANG
Publikováno v:
Chinese Journal of Lung Cancer, Vol 24, Iss 8, Pp 583-590 (2021)
Background and objective Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid growth, early metastasis and acquired therapeutic resistance, and the prognosis is extremely poor. Studies have proved that the stem cell
Externí odkaz:
https://doaj.org/article/9eaf84208d634deaa13266ec79f7a12b